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Neonatal treatment philosophy in Dutch and German NICUs: Health-Related Quality 
of Life in Adulthood of VP/VLBW infants 
 
Over the last two decades, survival after very preterm birth (VP; gestational age at birth <32 
weeks) and very low birth weight (VLBW; <1500 grams) has improved considerably [1]. 
Still, more VP/VLBW infants develop major cognitive impairments and physical disabilities 
such as cerebral palsy (CP), blindness, and deafness than full-term comparisons [2-3]. 
However, objective health states of chronic illnesses may only show a weak relationship to 
health related quality of life (HRQoL) [4] and may also depend on the informant of an 
individual’s HRQoL. Parents of preterm adolescents, but not the adolescents themselves, 
generally report a lower HRQoL than those of term-born children, especially in areas of 
motor, social, and emotional functioning [5]. Currently, only a few studies have examined 
VP/VLBW infants’ HRQoL longitudinally in adolescence [6] and in adulthood [4, 7-8]. It is 
important to follow-up VP/VLBW infants' HRQoL from adolescence into adulthood as it 
relates to real life implications such as job success, wealth, level of living independently, and 
social functioning such as dating a romantic partner and having friends [9-11]. To our 
knowledge, no study has yet compared HRQoL in VP/VLBW adults from different countries 
and has examined how different neonatal treatment and rates of disability affect HRQoL.  
 In the early 1980s, the neonatal treatment policy in The Netherlands could be 
described as “wait until certain” and intensive treatment for preterm children was initiated 
only when these infants showed a range of vital signs [6]. In contrast, neonatal treatment in 
Germany was given to infants of lower gestation than in The Netherlands and consisted of 
more intensive treatment such as initiating and maintaining mechanical ventilation for longer 
periods [6]. In recent years, there has been a move towards less intensive treatment including 
reduction of mechanical ventilation [12]. A comparison between countries with different 
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neonatal treatment philosophy provides a natural experiment to study potential effects on 
HRQoL. Previously, we reported that in early adolescence, extremely preterm Dutch 
adolescents scored higher on HRQoL than German adolescents [6]. These results were 
independent of birth weight, gestational age, and cerebral palsy, and were tentatively 
attributed to a better developing nervous system of Dutch VP/VLBW adolescents compared 
with German VP/VLBW adolescents, as a result of neonatal treatment differences. This study 
aimed to answer two research questions. First, do German and Dutch VP/VLBW still differ in 
HRQoL in adulthood? We expected Dutch VP/VLBW adults to score higher than German 
VP/VLBW adults on HRQoL, based on higher survival rates of German VP/VLBW infants 
with higher neonatal morbidity. Second, can differences between Dutch and German 
VP/VLBW adults' HRQoL be explained by neonatal health and treatment, social 
environment, and/or individual characteristics such as intelligence? We expected that 
neonatal health and treatment, social environment and intelligence would explain differences 
in HRQoL between Dutch and German VP/VLBW adults. 
 
Methods 
Participants 
HRQoL was assessed in VP/VLBW infants from two large prospective cohort studies in the 
Netherlands and Germany. Data from the Netherlands encompassed the national cohort of the 
Project On Preterm and Small-for-gestational-age infants (POPS). This cohort consists of 
1338 Dutch infants born premature in 133 obstetric departments between January 1983 and 
December 1983 in the Netherlands, 94% of all children born in 1983 in The Netherlands [13]. 
Of this cohort, 928 surviving VP/VLBW adults were eligible to participate in the follow-up 
data collection in adulthood between July and August 2011 at 28 years of age and 314 
(33.8%) participated. German data came from the Bavarian Longitudinal Study (BLS) of 682 
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VP/VLBW infants born in a geographically defined area of Southern Bavaria between 
January 1985 and March 1986 who required admission to one of 16 children’s hospitals 
within the first 10 days after birth [14]. Of this cohort, 411 surviving adults were eligible for 
inclusion and 260 (63%) participated in the adulthood data collection between September 
2010 and February 2014 (mean age 26.5 years (SD: 0.81), age range: 25.3-29.1 years). Figure 
1 presents the flow diagram of participants of both cohorts through the study. More 
information on these two cohorts can be found elsewhere [7, 15-16]. 
Ethical approval for these studies was obtained from the medical ethics committee of 
the Leiden University Medical Centre, the University of Munich Children’s Hospital, the 
Landesärztekammer Bayern, and the Ethical Board of the University Hospital Bonn. All 
participants gave fully informed written consent to participate in the study prior to the 
assessments in adulthood. In case of severe impairment of the adult participant, consent was 
provided by an assigned guardian (usually the parents). 
 
Measures 
Self-ratings were used to assess adults’ HRQoL. Assessments in adulthood were conducted at 
comparable ages; at age 28 years for the Dutch and at age 26 for the German cohort. Methods 
of data collection varied between cohorts. In the Netherlands, most VP/VLBW adults 
completed the HRQoL questionnaire online (n = 305, 97.1%), yet a small group completed 
the questionnaire on paper send by mail on request (n = 9, 2.9%). All questionnaires were 
completed by the VP/VLBW adults themselves. In Germany, most participants completed the 
questionnaires (paper version) during the follow-up visit in a quiet room (n = 202, 77.7%). 
Some respondents preferred a telephone interview (n = 21, 8.1%), while others preferred to 
complete questionnaires on paper send by mail (n = 13, 5.0%). For 14 (5.4%) German 
VP/VLBW adults, parents were used as proxy informants to rate their child’s HRQoL, due to 
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severe impairments of these VP/VLBW adults ( i.e., having a major handicap, such as severe 
CP, mental retardation, blindness or deafness).  
 The Health Utilities Index 3 (HUI3) is a widely used, comprehensive, multiplicative, 
multi-attribute approach to assess health status and HRQoL, encompassing eight attributes – 
vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain – with five to six 
levels of functioning per attribute. A utility score is determined based on population 
preferences derived from a Canadian normative sample that allows to convert the health-state 
description into a continuous multiple-attribute utility (MAU) score, ranging from 0 (dead) to 
1 (perfect health), although it is possible to have a score < 0, indicating health states worse 
than death [17]. The HUI3 is a holistic approach which provides a comprehensive yet 
compact way to describe the health status of an individual, which has been shown both 
reliable and valid [17-18], and has been used in a variety of clinical studies [4, 6-7]. 
The London Handicap Scale (LHS) also assesses HRQoL, focusing on six dimensions 
of disability: Mobility, physical independence (self-care), occupation (daily activities), social 
integration, orientation, and economic self-sufficiency. Every dimension consists of a six-
point hierarchical scale of disadvantages. To provide a generic measure of disability (scale 0 
to 1, where 1 is perfect health), each dimension of disability was recoded into a weighted 
score and the resulting six scores were summed into one generic measure of HRQoL [19]. 
The WHO Quality of Life instrument, short edition (WHOQOL-BREF) was developed 
to provide a cross-culturally validated measure of HRQoL. It provides a quality of life profile 
focusing on four domains: Physical health, psychological health, social relationships, and 
environment. Domain scores from the WHOQOL-BREF were transformed into weighted 
scores on a scale between 0-100, where 100 is perfect health [20]. 
Covariates: Very preterm birth (gestational age at birth <32 weeks) was determined 
from the date of the last menstrual period and serial ultrasounds during pregnancy in both 
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cohorts. Birth weight and sex were recorded at the time of birth. Duration of ventilator 
support (continuous positive airway pressure (CPAP) and/or mechanical ventilation) and 
duration of hospitalisation were recorded in both cohorts. Education of the parents was 
assessed at birth for the German sample and at age 5 years for the Dutch sample. For the 
Dutch cohort, when information about parent education at 5 years was unknown (8.7% 
missing data), parent education data at 10 years was used when available (26.4% of missing 
education data were replaced, resulting in 6.4% missing parent education data). The highest 
educational level of the parents in both cohorts was grouped as low (up to ten years of basic 
education), middle (vocational education), or high (professional education or university 
education). Adult intelligence (IQ) was assessed at different ages in both cohorts, yet IQ is 
highly stable in preterms from childhood onwards [21]. In the Dutch sample, adult IQ was 
assessed at 19 years with the use of the computer version of the Multicultural Capacity Test–
Intermediate Level, which provided full-scale IQ scores based on a broad spectrum of 
intelligence domains such as verbal and numerical factors, appreciation of spatial dimensions, 
fluent speech, memory, reasoning, and speed of perception [22]. IQ was assessed in the 
German sample at 26 years with the short version of the Wechsler Adult Intelligence Scale 
(WAIS III), which provided a full-scale IQ score based on six subtests: Vocabulary, 
similarities, letter-number-sequence, block design, matrix reasoning, and digit symbol coding 
[23-24].  
 
Data analysis 
Statistical significance was set at p <.05 and all tests were two-tailed. Selective attrition into 
adulthood was related to lower socioeconomic environment and/or more severe disabilities 
[7, 25]. Therefore, all analyses were run on both the adulthood samples (Dutch: n = 314; 
German: n = 260) and the full eligible samples with missing data imputed (Dutch: n = 928; 
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German: n = 411), to help interpret findings. Missing data were imputed in SPSS using 
predictive mean matching. Ten datasets were generated using ten iteration procedures. 
Imputed values were based on all variables in the model (HRQoL self-reports in adulthood 
and covariates). Additional predictors in the imputation model consisted of the HUI3 self-
reports in childhood (at 13 years for the German cohort, at 14 years for the Dutch cohort), 
HUI3 self-reports in adolescence (at 19 years, only available for the Dutch cohort), HUI3 
parent reports in adulthood (at 26 years for the German cohort, at 28 years for the Dutch 
cohort), LHS self-reports in adolescence (at 19 years, only available for Dutch cohort), and 
latest available childhood IQ score. 
To analyse whether cohorts differed in HRQoL in adulthood, linear regression 
analyses were performed for all three general HRQoL measures (HUI3, LHS, WHOQOL-
BREF) with cohort as a dummy variable. Cohort differences in HRQoL were interpreted 
using norms for clinical relevance (i.e. >.03) [18] as well as using Cohen’s d effect size [26]. 
To test whether cohorts differed in objective health states, logistic regression analyses were 
performed for the dichotomized health states representing optimal and suboptimal 
functioning (i.e., HUI3 attributes level 2 or above were recorded as suboptimal function) [6, 
25]. These cohort differences were interpreted using odds ratios. 
To test whether neonatal physical health and treatment, social environment, and 
intelligence are related to VP/VLBW adults’ HRQoL and cohort differences, we used 
hierarchical linear regression on the eligible sample with missing data imputed. To predict 
each of the three HRQoL scores (HUI3, LHS, WHOQOL-BREF) we included the following 
predictors in a stepwise fashion: First the neonatal predictors (cohort, gestational age, birth 
weight, gender, duration of continuous positive airway pressure (CPAP) / mechanical 
ventilation, duration of neonatal hospitalisation), and second, social environment assessed in 
childhood (parents’ education), and cognitive function assessed in adulthood (IQ scores). In a 
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third step, interactions of these predictors with cohort were also examined. Finally, we 
performed two additional checks on our data-analyses. First, we also run the same analyses 
on the adulthood sample, without missing data imputed. Second, because the HRQoL 
measures were highly skewed as most individuals report a good to optimal quality of life 
(ceiling effect) and as the assumption of homoscedasticity was not met, we rerun the analyses 
on the three outcome variables using logistic regression with (nearly) perfect health (HUI3 
cut-off: .95; LHS cut-off: .95; WHOQOL-BREF cut-off: 87) versus no perfect health. 
 
Results 
 
Dutch and German VP/VLBW cohorts 
Background characteristics of both Dutch and German VP/VLBW samples are presented in 
Table 1. German VP/VLBW survivors had a lower mean gestational age than Dutch 
VP/VLBW survivors. In addition, 7.1% (Dutch cohort, total n = 928) and 8.5% (German 
cohort, total n = 411) of the infants were born before 28 weeks of gestation. Both groups had 
approximately the same birth weight. German VP/VLBW survivors more often received 
ventilator support, spent more days on ventilator support, and spent more days in hospital 
than Dutch VP/VLBW survivors. In both cohorts, participants in adulthood did not differ 
from dropouts in terms of gestational age, birth weight, days of ventilation and days of 
neonatal hospitalization. Only in the Dutch cohort, more males dropped out, resulting in 
significantly more females in the Dutch compared with the German sample in adulthood. 
More Dutch VP/VLBW had parents with either lower or higher education than German 
VP/VLBW individuals, who more often came from families with educational backgrounds 
classified as “middle”. In both cohorts, VP/VLBW adults from lower educated families more 
often dropped out.  
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Next to neonatal predictors, intelligence of Dutch and German VP/VLBW individuals 
was assessed in adulthood. IQ scores were significantly higher for Dutch (mean IQ = 103.8; n 
= 251) than German (mean IQ = 89.2; n = 202; p <.001) VP/VLBW adults. To impute 
missing adulthood IQ values for the full eligible sample, the latest available childhood IQ 
score was included as a predictor in the imputation model. Yet, even in the full eligible 
sample with missing data imputed, Dutch (mean IQ = 98.0; n = 928) had higher mean IQ 
scores than German (mean IQ = 88.4; n = 411; p <.001) VP/VLBW adults. 
 
Differences across VP/VLBW cohorts in HRQoL and health states 
Test of differences in HRQoL scores across German and Dutch VP/VLBW adults are 
presented in Table 2. Analyses on both the adult samples and full eligible samples (with 
missing data imputed) showed that the Dutch VP/VLBW adults reported a significantly 
higher HRQoL for all three general HRQoL measures (HUI3, LHS, WHOQOL-BREF) than 
German VP/VLBW adults. These differences were, however, small according to Cohen, yet 
clinically relevant according to the HUI3 scale developers (>.03 points) [18, 26]. Specifically, 
more optimal health states were reported for Dutch than for German VP/VLBW adults in 
areas of vision and cognitive ability. Also, more Dutch than German VP/VLBW adults 
reported high emotional health, however, this difference disappeared when missing data were 
imputed. 
 
Explaining cohort differences in HRQoL 
Table 3 shows that cohort differences in HRQoL scores were either partially (WHOQOL-
BREF) or fully (HUI3, LHS) explained when taking into account other important predictors 
of HRQoL. For all three HRQoL measures (HUI3, LHS, WHOQOL-BREF), adult IQ was the 
main predictor. Duration of neonatal ventilation also predicted differences in LHS, but this 
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effect disappeared when taking into account adult IQ. Hospitalisation length also tended to be 
related to HUI3 (p = .061), but this small effect also disappeared when adult IQ was included. 
These results suggests an overlap in explained variance by the functional measure of IQ. 
Interaction effects of cohort with other predictors including intelligence (eight interactions for 
three outcome variables) did not significantly add to the prediction of HRQoL scores and are 
therefore not included in Table 3.  
The results of the linear regression analyses for the eligible sample with missing data 
imputed presented in Table 3 are relatively similar to both the results for the adulthood 
sample (no imputation of missing data) and the logistic regression analyses. Therefore, we 
only present the results of these additional data checks online in Supplement Table S1 and 
S2. 
 
Discussion 
This study examined HRQoL in adults born VP/VLBW, by comparing VP/VLBW cohorts 
from two European countries: The Netherlands and Germany. These countries differed in 
neonatal treatment policies in the 1980’s with the Dutch policy initiating intensive treatment 
only if VP/VLBW infants’ survival was highly likely. We found differences in German and 
Dutch VP/VLBW adults’ HRQoL scores across all three different measures of HRQL. These 
differences reduced ‒ but remained significant ‒ once accounted for selective attrition in the 
imputed samples. Our findings on HRQoL in VP/VLBW adults concur with previous 
findings for extremely low birthweight (<1000g) adolescents [6] and imply that country 
differences in treatment policy relate to VP/VLBW cohort differences in HRQoL. This study 
adds to previous work by including neonatal factors, SES, and cognitive function as 
predictors of adults’ HRQoL to help explain differences in HRQoL between VP/VLBW 
adults from different countries. 
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In both cohorts, functional cognitive ability (IQ) was found to be the main 
independent predictor of HRQoL in VP/VLBW adults, independent of the specific measure 
used. In general, our results indicate that lower HRQoL in German VP/VLBW survivors in 
adulthood is mainly related to their lower IQ after VP/VLBW birth compared to Dutch 
VP/VLBW. In addition, the effect of treatment factors such as ventilation or hospitalisation 
length reduced once the functional outcome IQ was considered as predictor of HRQoL. These 
results implicate that IQ may mediate the pathway from early VP/VLBW treatment to 
HRQoL in adulthood, consistent with previous research showing that both ventilation and 
length of hospitalisation are strong predictors of childhood IQ in VP/VLBW children [12] 
and that objective functioning is related to HRQoL in VP/VLBW adolescents [25]. 
 Our findings stress the impact of cognitive function in VP/VLBW adults’ life. IQ is an 
important marker of VP/VLBW brain health [27]. First, VP/VLBW birth is related to brain 
injuries that affect brain organization [28-29] and second, neonatal complications and 
mechanical ventilation in particular have been shown to lead to alterations in brain structure 
with adverse effects on cognitive functioning [30]. Even small IQ differences are important 
as they are not only related ‒ as shown here ‒ to HRQoL, but also to socioeconomic status 
and even reduced survival and health into old age [31-32]. 
Although IQ explained most differences in HRQoL between Dutch and German 
VP/VLBW adults, the differences were nevertheless real and clinically relevant. Dutch and 
German HRQoL as measured with HUI3 MAU scores differed by approximately .03 points, a 
difference previously considered to be clinically important [18]. Analyses on the health states 
showed that in addition to differences in cognition, more German than Dutch VP/VLBW 
adults had problems with vision and lower emotional health (although this effect disappeared 
when missing data were imputed). In addition, Dutch VP/VLBW adults still indicated higher 
HRQoL than German VP/VLBW adults on the physical WHOQOL-BREF HRQoL measure 
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when corrected for neonatal treatment, SES, and IQ. Cohort differences in WHOQOL-BREF 
may thus be related to country differences such as social-economic differences and/or cultural 
differences in attitudes regarding disabilities and handicaps not measured in this study or to 
general differences in experienced wellbeing between countries, not related to preterm birth. 
For example, UNICEF reported that from the 29 countries with most advanced economies, 
The Netherlands were the leader for child wellbeing, measured both objectively and with 
self-reports. In comparison, Germany occupied 6th place according to objective measures of 
wellbeing, but dropped to 22nd place when children themselves were asked to evaluate their 
life satisfaction. 
Because of the found country differences in neonatal treatment and HRQoL, findings 
on VP/VLBW adult HRQoL may be quite country specific and thus not generalizable to other 
VP/VLBW populations. In contrast, our results indicate that the impact of cognitive function 
on adult HRQoL may be robust. Regarding the current population of VP/VLBW infants, 
future research must demonstrate whether the improvement of neonatal treatments and 
especially the development of less invasive treatments may lead to better cognitive 
development and thereby improved HRQoL or whether any gains through improved neonatal 
treatment will be nullified by more infants of smaller gestation surviving. Prospective cohort 
studies are essential in providing this information. 
This study has a range of strengths. Most important among these are the long-term 
follow-up into adulthood of two large whole population samples of VP/VLBW individuals 
from two different European countries that had different neonatal treatment policies in the 
1980’s and the assessment of HRQoL in adulthood with multiple identical instruments. There 
are also limitations. First, adulthood response rates between the two countries differed largely 
and the dropout was not random. VP/VLBW with lower educated parents were less likely to 
continue participation, which is in line with previous reports that participants at social 
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disadvantage are more likely to drop out of longitudinal studies than those more socio-
economically advantaged [33]. In addition, for the Dutch VP/VLBW, gender also impacted 
dropout with females more likely to participate in adulthood. This finding again stresses the 
need to report on findings that are corrected for selective attrition. Thus, we report on the 
adult sample with available data and on the full eligible sample with imputed missing data to 
control for possible bias. Yet, the findings were generally consistent, independent of the 
chosen sample. Second, because studies were performed in two countries under the guidance 
of two research teams, not all predictor variables were measured identically or could be 
measured identically. For example, adulthood IQ was assessed with different measures in 
both cohorts and different measures show different secular trends (i.e., Flynn effect) [34]. 
Nevertheless, additional analyses done separately for each country showed similar effects of 
IQ on HRQoL, indicating a true effect independent of how and when IQ was measured. Also, 
Dutch and German educational systems differ and are thus not exactly comparable, which 
was why parent education was categorized in three general, more comparable, classes (i.e., 
low, middle, high). 
 
Conclusion 
The present study showed that German VP/VLBW adults had lower quality of life compared 
with Dutch VP/VLBW adults. These differences were related to German VP/VLBW adults 
having higher levels of cognitive impairment than Dutch VP/VLBW adults, which was in 
turn related to German VP/VLBW infants receiving more intensive neonatal treatment while 
the Dutch policy initiated intensive treatment only if VP/VLBW infants’ survival was highly 
likely. Thus, intensive neonatal treatment may reduce cognitive abilities which in turn 
increases VP/VLBW adults’ vulnerability to a lower HRQoL with long-lasting consequences 
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into adulthood. Our findings stress the importance of examining effects of cross-cultural 
differences in neonatal treatment policies and their consequences for VP/VLBW adults’ life.  
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